[1]
Akimov, A. and Cherniavskyi , V. 2025. Comparative effects of liraglutide and dapagliflozin on lipid profile and cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: a 6-month randomized study. The Ukrainian Scientific Medical Youth Journal. 158, 4 (Dec. 2025), 17-26. DOI:https://doi.org/10.32345/USMYJ.4(158).2025.17-26.